Michael Truett Tate sold $45M of ALAB
Chief Financial Officer at Astera Labs, Inc.. 500,000 shares at an average of $90.23, traded May 30, 2025, filed Jun 3, 2025.
Score components
- +22RoleCFO
- +25Trade size$45.1M at market
- +10Share of holdings soldSold 45% of holdings
- +15Cluster5 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-25-029091, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 30, 2025 | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -19,998 | $88.14 | $1.8M | 1,098,998 | Jun 3, 2025 |
| May 30, 2025 | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -92,200 | $89.05 | $8.2M | 1,006,798 | Jun 3, 2025 |
| May 30, 2025 | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -156,288 | $90.06 | $14M | 850,510 | Jun 3, 2025 |
| May 30, 2025 | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -204,954 | $90.75 | $19M | 645,556 | Jun 3, 2025 |
| May 30, 2025 | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -15,492 | $92.04 | $1.4M | 630,064 | Jun 3, 2025 |
| May 30, 2025 | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -3,968 | $92.96 | $369k | 626,096 | Jun 3, 2025 |
| May 30, 2025 | SOpen-market sale Common Stockindirect: By Tate Trust10b5-1 | -7,100 | $94.33 | $670k | 618,996 | Jun 3, 2025 |
Related signals
Other insiders at Astera Labs, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | Astera Labs, Inc. | Stefan A Dyckerhoff director | $4.7M 12,499 shares | -25% | |
| 33Weak | Astera Labs, Inc. | Manuel Alba director | $51M 183,000 shares | -14% | |
| 33Weak | Astera Labs, Inc. | Stefan A Dyckerhoff director | $3.4M 12,499 shares | -23% | |
| 17Weak | Astera Labs, Inc. | Bethany Mayer director | $60k 686 shares | -10% | |
| 35Weak | Astera Labs, Inc. | Manuel Alba director | $2.0M 20,150 shares | -5% | |
| 45Moderate | Astera Labs, Inc. | Jitendra Mohan Chief Executive Officer | $5.3M 52,743 shares | -1% | |
| 40Moderate | Astera Labs, Inc. | Sanjay Gajendra President and COO | $7.5M 76,373 shares | -1% | |
| 45Moderate | Astera Labs, Inc. | Jitendra Mohan Chief Executive Officer | $10M 106,510 shares | -2% | |
| 40Moderate | Astera Labs, Inc. | Sanjay Gajendra President and COO | $8.7M 88,627 shares | -1% | |
| 17Weak | Astera Labs, Inc. | Manuel Alba director | $60k 600 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.